Radiopharmaceuticals can be divided into radioactive molecules or radionuclides that facilitate diagnostic imaging and radiotherapy. Before being used in the clinical setting, all commercially produced radiopharmaceuticals must be approved by the US Food and Drug Administration (FDA).
Also, radiopharmaceuticals must possess various characteristics to be desirable for nuclear medicine applications. Radionuclide decay should be able to produce gamma emissions of suitable energy for diagnostic imaging. The ideal energy for a gamma camera is 100-200 keV, compared to 511 keV for positron emission tomography imaging.
Radiopharmaceuticals should not contain particle radiation, such as beta emissions, which can contribute to the patient’s radiation doses, even though beta emissions have therapeutic properties.
Furthermore, radionuclides should have an effective half-life for clinical applications. They should also be carrier-free and not contaminated with a stable radionuclide. If the specific activity changes, this can harm biodistribution and labelling efficiency.
Considering all the above, one of the best radionuclides for radiopharmaceuticals is technetium-99m, especially for gamma camera imaging. The radiopharmaceutical should rapidly localise in a specific part of the body according to the intended application. Background clearance should also be rapid to achieve reasonable target-to-background ratios.
Radiotherapy treatments involving the radionuclide attached to a vector (antibody) to deliver radioactivity to specific cells are called radioimmunotherapy.
For example, the radiopharmaceutical iodine-131 tositumomab, yttrium-90 ibritumomab and yttrium-90 epratuzumab are used to treat non-Hodgkin’s lymphoma.
Also, samarium-153 (Quadramet) is effective in relieving the pain of bone cancer and prostate and breast cancer. The most used radioisotope for treating bone metastasis in the US is samarium-153 EDTMP (lexidronam).
The pure beta emitter yttrium-90 is used to relieve the pain of arthritis in larger synovial joints. Other radiopharmaceuticals include Iofetamine (I-123 iodoamphetamine), used for non-invasive evaluation of local cerebral blood flow in cerebrovascular accidents, and dysprosium, used as an aggregated hydroxide for synovectomy (removal of synovial tissue surrounding a joint ) treatment of arthritis.
You are here:
home »
Tritium radiolabelling of APIs enables precise tracking of drug distribution, metabolism, and bioavailability in pharmaceutical studies.
Revolutionising Drug Research: Tritium Radiolabelling of APIs Read Post »
The fine-structure constant, denoted by α, is fundamental in understanding electromagnetic interactions between charged particles in physics.
The Fine-Structure Constant: Decoding the Strength of Electromagnetic Interactions Read Post »
Radioactive decay of Carbon-14 enables scientists to determine ages of ancient artefacts, fossils, and environmental samples accurately.
Understanding the Radioactive Decay of Carbon-14 and Its Applications Read Post »
Carbon-14 microtracers offer unparalleled precision in tracking molecular pathways, advancing drug development, environmental, and nutritional research.
Carbon-14 Microtracers: Revolutionising Drug Research and Discovery Read Post »
Carbon-14 radiolabelling enables researchers to trace drug metabolism precisely, aiding in comprehensive ADME studies and safety assessments.
The Role of Carbon-14 Radiolabelling in ADME Studies Read Post »
Cancer radiotheranostics combines targeted radiotherapy and diagnostic imaging to provide personalised, precise, and effective cancer treatment.
Cancer Radiotheranostics: The Future of Targeted Cancer Therapy Read Post »
The atomic mass unit (amu) allows scientists to measure atomic and molecular masses with remarkable precision.
Atomic Mass Unit: Unlocking the Secrets of Matter Read Post »
FLYRCADO is an innovative radiopharmaceutical agent specifically designed for use in Positron Emission Tomography (PET) Myocardial Perfusion Imaging (MPI). It
FLYRCADO in Positron Emission Tomography (PET) Myocardial Perfusion Imaging Read Post »
The regulations in 21 CFR Part 212 ensure PET drugs are manufactured under strict quality control and safety standards.
Ensuring Quality and Compliance: A Guide to 21 CFR Part 212 for PET Drug Manufacturing Read Post »
Good Manufacturing Practices ensure the consistent quality, safety, and efficacy of pharmaceutical products through rigorous production standards.
Overview of Good Manufacturing Practices (GMP) in Radiopharmaceuticals Read Post »
Regulatory radiopharmaceutical production requires strict adherence to safety standards, ensuring quality and patient safety.
Regulatory Considerations in Radiopharmaceutical Production Read Post »
Radiotheranostic treatments combine diagnostic imaging with targeted radiopharmaceutical therapy, providing personalised cancer care with enhanced precision and effectiveness.
Radiotheranostic Treatments: A Guide to Types and Their Clinical Applications Read Post »
Radiotheranostics offers a precise, personalised approach to cancer treatment by combining diagnostic imaging with targeted therapy
The Future of Radiotheranostics: A New Frontier in Precision Medicine Read Post »
The article explores the theranostic applications of Terbium radionuclides, highlighting their diagnostic and therapeutic potential in nuclear medicine.
Terbium Radionuclides for Theranostic Applications in Nuclear Medicine Read Post »
Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer’s disease diagnosis and study.
Radiopharmacy combines the disciplines of pharmacy and nuclear science to create radiopharmaceuticals, revolutionising the diagnosis and treatment of diseases.
Radiopharmacy: Harnessing Radioactive Compounds for Diagnosis and Treatment Read Post »
Neuroimaging in nuclear medicine allows for detailed visualisation of brain activity, aiding in diagnosing complex neurological conditions.
Unlocking the Mysteries of the Brain: Neuroimaging in Nuclear Medicine Read Post »
The synthesis of Fluorine-18 for advanced PET imaging requires precise cyclotron bombardment, purification, and automation technologies.
Synthesis of Fluorine-18 for Advanced PET Imaging Read Post »
PET scans are crucial for detecting metabolic activity, providing valuable insights into cancer, neurological disorders, and cardiovascular diseases.
The gamma camera allows non-invasive imaging, enabling detailed diagnosis and monitoring of various medical conditions with precision.
The Role of the Medical Gamma Camera in Modern Healthcare Read Post »
Nuclear chemistry provides critical insights into energy production, medical advancements, and environmental protection, shaping a sustainable future.
Exploring Nuclear Chemistry: Innovations, Applications, and Future Prospects Read Post »
History of Radiochemistry chronicles its evolution from the discovery of radioactivity to modern applications in science and medicine.
A Brief History of Radiochemistry from Discovery to Modern Applications Read Post »
Radionuclide production, encompassing reactor-based, cyclotron, and generator methods, is essential for medical, industrial, and research applications worldwide.
Radionuclide Production: Methods and Applications Read Post »
Radiotheranostic Pairs combine diagnostic imaging with targeted radiotherapy, revolutionising personalised cancer treatment through enhanced precision and efficacy.
Radiotheranostic Pairs: Bridging Diagnostics and Therapeutics in Cancer Read Post »
Radiotheranostics combines diagnostic imaging and targeted radiotherapy, using radiopharmaceuticals for personalised, precise cancer treatment and improved outcomes.
What is Radiotheranostics? The Future of Personalised Cancer Diagnosis Read Post »
Introduction to Hybrid Medical Scanners Hybrid scanners represent a significant leap forward in medical imaging technology by combining different imaging
The Power of Hybrid Medical Scanners: Integrating PET, CT, MRI, and SPECT Read Post »
Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically.
Breakthroughs in Positron Emission Tomography Imaging Read Post »
Q&A – Medical Imaging Modalities and Therapy explores innovative techniques and advancements in diagnostic and therapeutic imaging applications.
Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases.
Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals Read Post »
Therapeutic nuclear medicine leverages radionuclides for targeted cancer treatment, facing challenges in delivery, safety, and regulatory compliance.
PET imaging dramatically enhances early disease detection, significantly improving patient outcomes in various medical fields.
PET Imaging and Its Transformative Impact in Modern Medicine Read Post »
Thorium-227 emerges in nuclear medicine, revolutionizing cancer treatment through precise, effective radiotheranostic and therapeutic applications.
The Breakthrough Role of Thorium-227 in Theranostic Radiopharmaceuticals Read Post »
FAPI revolutionises oncology with precise Gallium-68 diagnostics and targeted Lutetium-177 therapy for cancer.
Somatostatin Receptor Targeting Agents offer groundbreaking diagnostic and therapeutic solutions for neuroendocrine tumour management and care.
Somatostatin Receptor Targeting Agents: Revolutionising Neuroendocrine Tumour Management Read Post »
225Ac-MTI-201, targeting MC1R, offers groundbreaking, targeted treatment for uveal melanoma with minimal side effects.
Actinium-225 MTI-201: A Promising New Agent in Uveal Melanoma Treatment Read Post »
Actinium-225 is a rare, promising isotope revolutionizing targeted alpha therapy for various resistant cancers.
Actinium-225: The Emerging Star in Targeted Alpha Therapy Read Post »
225Ac-FPI-2068 and 111In-FPI-2107 represent a major advancement in targeted alpha therapy for various solid tumours.
225Ac-FPI-1434 advances in clinical trials, targeting IGF-1R in chemo-resistant solid tumors with promising results.
225Ac-DOTAZOL enhances 177Lu-radiotherapy in bone diseases, particularly effective in prostate cancer, as shown in preclinical studies.
225Ac-DOTATOC advances GEP-NET treatment, offering targeted, effective therapy for patients resistant to traditional methods.
225Ac-DOTA-YS5 targets CD46 in prostate cancer, promising precision and effectiveness in therapy.
225Ac-DOTA-SP, a breakthrough in targeted alpha therapy, offers precise cancer treatment with minimal side effects, revolutionising oncological approaches.
Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine.
The Transformative Impact of Radiopharmaceuticals in Medical Imaging Read Post »
Zirconium radiopharmaceuticals enhance nuclear medicine with precise diagnostics and potential therapeutic applications.
Zirconium Radiopharmaceuticals in Nuclear Medicine Read Post »
Lutetium radiopharmaceuticals significantly advance targeted cancer treatment and diagnostic capabilities.
Lutetium Radiopharmaceuticals in Medicine: A Comprehensive Review Read Post »
Lead radiopharmaceuticals herald a transformative era in cancer treatment with promising, targeted therapeutic approaches.
Transforming Cancer Treatment: The Promising Future of Lead Radiopharmaceuticals Read Post »
Gallium, predicted by Mendeleev, now revolutionises medical diagnostics with its unique radiopharmaceutical applications in oncology.
In Brazil, the growing radiopharmaceutical market, driven by chronic disease and advanced imaging technologies, is becoming increasingly significant in healthcare.
Advancing Healthcare: The Dynamic Growth of Brazil’s Radiopharmaceutical Market Read Post »
Technetium-99m, discovered in 1937, transformed medical imaging with its versatile and safe diagnostic applications.
Technetium-99m Radiopharmaceuticals in Advanced Medical Imaging Read Post »
Copper radiopharmaceuticals offer groundbreaking diagnostic and therapeutic applications, revolutionising nuclear medicine, particularly in oncology and cardiology.
Exploring Copper Radiopharmaceuticals: Innovations and Applications in Nuclear Medicine Read Post »
From Becquerel’s discovery in 1896 to modern medical applications, radionuclides have revolutionised our approach to science, medicine, and industry.
Radionuclides from Discovery to Modern Medical Imaging Read Post »
[F-18]NAV-4694 shows promise in Alzheimer’s detection, with a strong safety profile and clear regulatory pathways.
Alzheimer’s disease stems from genetic mutations and lifestyle factors, leading to brain plaque accumulation and dementia.
Immuno-PET merges monoclonal antibodies with PET imaging, transforming precision oncology through enhanced tumor detection and monitoring.
Immuno-PET: Cancer Detection and Treatment in Nuclear Medicine Read Post »
Cyclotrons advance nuclear medicine by efficiently producing key radionuclides for diagnostics and treatment within hospital settings.
The Pivotal Role of Cyclotrons in Radionuclide Production Read Post »
Zevalin, combining monoclonal antibodies and radiation, offers hope against refractory B-cell non-Hodgkin’s lymphoma with targeted therapy.
Yttrium-90 chloride is pivotal in radioimmunotherapy, targeting cancer cells precisely while minimizing damage to surrounding tissues.
Yttrium-90 Chloride: A Vital Component in Radioimmunotherapy Read Post »
Xenon-133 is pivotal for imaging lungs and assessing brain flow, enhancing diagnoses in modern medicine.
Xenon-133: A Radiographic Cornerstone in Pulmonary and Cerebral Diagnostic Imaging Read Post »
Thallium-201 chloride is pivotal in myocardial perfusion imaging, diagnosing ischemic heart disease, and assessing myocardial viability.
Technetium-99m sulfur colloid provides critical diagnostics for liver, spleen, and bone marrow using targeted nuclear imaging.
The Role of Technetium-99m Sulfur Colloid in Diagnostic Imaging Read Post »
Technetium-99m UltraTag RBCs enhance blood pool imaging and precisely localize gastrointestinal bleeding in non-invasive diagnostic procedures.
Technetium-99m medronate is vital in nuclear medicine for precise bone imaging and detecting osteogenesis abnormalities.
Technetium-99m Medronate (MDP-25): Bone Imaging and Osteogenesis Evaluation Read Post »
Technetium-99m Mebrofenin is pivotal for hepatobiliary imaging, assessing liver function, gallbladder diseases, and biliary obstructions.
Strontium-89 chloride: a potent palliative for metastatic bone cancer-induced pain, through calcium-mimicking, localized beta radiation, ensuring effective, safer pain relief.
Alleviating Metastatic Bone Pain: The Role of Strontium-89 Chloride in Palliative Care Read Post »
The Molybdenum-99 Generator crucially produces Technetium-99m for medical imaging, through radioactive decay, aiding numerous diagnostic procedures globally.
Molybdenum-99 Generator and its Impact on Medical Imaging Read Post »
Positrons, alpha particles, beta particles, and electron capture contribute to nuclear medicine, diagnostics, and diverse scientific applications.
Lutetium-177 Dotatate selectively binds to SSTRs on NET cells, delivering targeted radiation, minimizing collateral damage, and reducing side effects.
Lutetium-177 Dotatate: A Novel Therapeutic Approach in Neuroendocrine Tumours Read Post »
Iodine-131 sodium iodide, a radioactive isotope, is used in diagnosing and treating thyroid disorders and specific cancer therapies.
Iodine-131 Sodium Iodide: Thyroid Disorder Diagnosis and Treatment Read Post »
Iodine-131 Iobenguane (I-131 MIBG), a radiopharmaceutical agent, enables early diagnosis and targeted treatment of neuroendocrine tumours, improving patient outcomes.
Iodine-131 human serum albumin offers versatile diagnostic and therapeutic applications, despite limitations like radiation exposure and a short half-life.
Indium-111 pentetreotide excels in detecting and localising neuroendocrine tumors, monitoring treatment, and identifying therapy candidates.
Indium-111 Pentetreotide: A Valuable Tool in Nuclear Medicine Read Post »
Fluorine-18 Fluoroestradiol PET imaging enables early breast cancer detection, accurate staging, and treatment response monitoring, improving patient outcomes.
Fluorine-18 Fluoroestradiol: A Promising Tool for Breast Cancer Imaging Read Post »
Iodine-125 iothalamate, with high albumin affinity, ensures accurate GFR measurement, minimal radiation exposure, stability, and cost-effectiveness in diagnostics.
Iodine-125 Iothalamate: Diagnostic Imaging and Renal Function Read Post »
Iodine-125 Human Serum Albumin effectively measures blood volume, assesses vascular permeability, and evaluates protein-losing gastroenteropathy for accurate diagnosis.
Iodine-125 Human Serum Albumin: A Radiolabelled Diagnostic Agent Read Post »
Iodine-123 Sodium Iodide capsules aid in diagnosing thyroid disorders, providing vital insights into thyroid function and structure.
Iodine-123 Sodium Iodide Capsules: A Diagnostic Tool for Thyroid Disorders Read Post »
Iodine-123 Ioflupane known as DaTscan aids in diagnosing Parkinson’s disease by visualising dopamine transporters using SPECT imaging.
Iodine-123 Ioflupane (DaTscan): Diagnosis of Parkinson’s Disease and Movement Disorders Read Post »
Iodine-123 iobenguane is vital for detecting, staging, and monitoring neuroendocrine tumours, guiding treatment, and offering prognostic insights.
Iodine-123 Iobenguane: Diagnosis and Evaluation of Neuroendocrine Tumours Read Post »
Indium-111 Pentetate enables tumour detection, infection, inflammation tracking, and cerebrospinal fluid leak identification.
Indium-111 Pentetate: Targeted Therapy in Oncology, Infection, and Inflammation Read Post »
Indium-111 oxyquinoline enables diverse cellular imaging, crucial for detecting infections, thrombosis, tumours, and advancing stem cell research.
Indium-111 Oxyquinoline: A Versatile Radiopharmaceutical Agent Read Post »
Indium-111 chloride effectively aids infection and inflammation imaging by labelling WBCs, enabling precise issue localisation and severity assessment.
Indium-111 Chloride: A Prominent Radiotracer in Nuclear Medicine Read Post »
Gallium-68 Gozetotide enhances PET imaging for oncology, targeting somatostatin receptors, and offering improved tumour detection and patient care.
Gallium-68 Gozetotide: A Radiopharmaceutical Agent for PET Imaging Read Post »
Gallium-68 DOTATOC revolutionises neuroendocrine tumor diagnosis, enhancing PET imaging accuracy, sensitivity, and management in the medical field.
Gallium-68 DOTATOC: PET Imaging of Neuroendocrine Tumour Read Post »
Alzheimer’s disease, an age-related neurodegenerative disorder, impacts brain structure and function, requiring advanced imaging techniques for improved understanding and diagnosis.
Brain Imaging in Alzheimer’s Disease: Techniques, Advancements, and Challenges Read Post »
Gallium-68 DOTATATE, a radiopharmaceutical, targets somatostatin receptors, aiding neuroendocrine tumor detection through PET imaging, enhancing diagnostic accuracy and patient outcomes.
Gallium-68 DOTATATE: A Novel Diagnostic Tool for Neuroendocrine Tumours Read Post »
Gallium-67 citrate is a radiopharmaceutical used for imaging infections, inflammation, cancer, and fever of unknown origin.
Gallium-67 Citrate: A Versatile Diagnostic Agent Read Post »
Fluorine-18 Flutemetamol, a radioactive tracer, for early detection of Alzheimer’s disease through PET imaging, enhancing diagnostic accuracy.
Fluorine-18 Flutemetamol: An Imaging Agent Revolutionising Alzheimer’s Disease Diagnosis Read Post »
Fluorine-18 Fludeoxyglucose, a radiotracer used in PET scans, enables precise cancer diagnosis, evaluating metabolic activity, and monitoring treatment efficacy non-invasively.
Fluorine-18 Fludeoxyglucose: A Key Radiotracer in Positron Emission Tomography Read Post »
Fluorine-18 Flucicovine (Axumin) improves prostate cancer detection, enabling accurate diagnosis and targeted treatments with PET imaging.
Fluorine-18 Florbetapir, radiotracer, amyloid plaques, Alzheimer’s disease, PET imaging, early diagnosis, pharmaceutical research, neurodegenerative disorders, brain.
Fluorine-18 Florbetapir: An Essential Tool for Diagnosing Alzheimer’s Disease Read Post »
Fluorine-18 Florbetaben is a radiotracer used in medical imaging to detect amyloid plaques in the brain.
Fluorine-18 Florbetaben: An Advanced Radiotracer for Alzheimer’s Disease Detection Read Post »
Copper-64 DOTATE, a diagnostic radiopharmaceutical, effectively targets neuroendocrine tumours, enabling precise imaging and personalised treatment plans for cancer patients.
Carbon-14 urea, utilised in breath tests, effectively detects Helicobacter pylori infections, aiding gastric ulcer diagnosis and management.
Carbon-14 Urea: A Non-Invasive Diagnostic Tool for Gastrointestinal Disorders Read Post »
Carbon-14 Choline, a radioactive isotope, improves medical imaging accuracy and expands molecular research, aiding cancer diagnosis and treatment.
Carbon-11 Choline: A Radiopharmaceutical with Expanding Applications Read Post »
SPECT imaging provides valuable functional information, aiding clinicians in diagnosing, planning treatments, and monitoring progress.
SPECT Imaging Technology: From Single Photon Emission Tomography to Hybrids Read Post »
Theranostics is a cutting-edge approach that integrates diagnosis and therapy, enabling personalised and precise disease management.
Personalised Theranostics for Cancer: A New Era in Precision Medicine Read Post »
Imaging agents can be used to evaluate organ function, detect cancer, measure blood flow and follow metabolic processes.
Radiometals for diagnostic imaging and theranostics Read Post »
Radiopharmaceuticals are used in nuclear medicine for the application of medical imaging and therapy.
Radiopharmaceuticals enhance PET and SPECT imaging, enabling precise visualisation of physiological processes.
Radiopharmaceuticals in PET and SPECT Imaging: From Research to Clinical Practice Read Post »
Application of aptamers in drug delivery systems and radiopharmacy.
Nano-aptamer for breast cancer imaging: initial considerations Read Post »
A method uses polylactic acid as the polymer to encapsulate nano-hydroxyapatite.
![Automated synthesis of [18F]fluorocholine using a modified GE tracerlab module](https://openmedscience.com/wp-content/uploads/2020/05/18-F-fluorocholine-used-in-oncology-pet-imaging-2048x2048.jpg.webp)
Automated radiosynthesis of fluorine-18 choline using a modified TracerLab module.
Automated synthesis of [18F]fluorocholine using a modified GE tracerlab module Read Post »
